Unique properties of polyphenol stilbenes in the brain: More than direct antioxidant actions; gene/protein regulatory activity

NeuroSignals

Volumn 14, Issue 1-2, 2005, Pages 61-70

  Doré, Sylvain ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bilirubin; Biliverdin; Blood flow; Carbon monoxide; Hemin; Iron

Indexed keywords

ANTIOXIDANT; BILIRUBIN; CARBON MONOXIDE; HEME; HEME OXYGENASE; IRON; POLYPHENOL DERIVATIVE; RESVERATROL; SCAVENGER; STILBENE DERIVATIVE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; BLOOD FLOW; BRAIN; CELL PROTECTION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RED WINE; REVIEW; STATISTICAL SIGNIFICANCE; STROKE; VASCULAR DISEASE;

ANIMALS; ANTIOXIDANTS; CEREBROVASCULAR DISORDERS; ENCEPHALITIS; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME OXYGENASE (DECYCLIZING); HUMANS; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHENOLS; STILBENES;

EID: 20944445992     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085386     Document Type: Review

References (102)

1. Renaud S, de Lorgeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-1526.
2. Sato M, Ray PS, Maulik G, Maulik N, Engelman RM, Bertelli AA, Bertelli A, Das DK: Myocardial protection with red wine extract. J Cardiovasc Pharmacol 2000;35:263-268.
3. Soleas GJ, Diamandis EP, Goldberg DM: Resveratrol: A molecule whose time has come? And gone? Clin Biochem 1997;30:91-113.
4. Goldberg D, Tsang E, Karumanchiri A, Diamandis E, Soleas G, Ng E: Method to assay the concentrations of phenolic constituents of biological interest in wines. Anal Chem 1996;68:1688-1694.
5. Celotti E, Ferrarini R, Zironi R, Conte LS: Resveratrol content of some wines obtained from dried Valpolicella grapes: Recioto and Amarone. J Chromatogr [A] 1996;730:47-52.
6. Zhuang H, Kim YS, Koehler RC, Doré S: Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann NY Acad Sci 2003;993:276-286.
7. Doré S: Decreased activity of the antioxidant heme oxygenase enzyme: Implications in ischemia and in Alzheimer's disease. Free Radic Biol Med 2002;32:1276-1282.
8. Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F: Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 2004;40:138-145.
9. Wang YJ, He F, Li XL: The neuroprotection of resveratrol in the experimental cerebral ischemia. Zhonghua Yi Xue Za Zhi 2003;83:534-536.
10. Virgili M, Contestabile A: Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine anti-oxidant agent, trans-resveratrol in rats. Neurosci Lett 2000;281:123-126.
11. Huang SS, Tsai MC, Chih CL, Hung LM, Tsai SK: Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 2001;69:1057-1065.
12. Sinha K, Chaudhary G, Gupta YK: Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002;71:655-665.
13. + channels: Physiological role and pharmacology. Curr Med Chem 2003;10:649-661.
14. Karlsson J, Emgard M, Brundin P, Burkitt MJ: Trans-resveratrol protects embryonic mesencephalic cells from tert-butyl hydroperoxide: Electron paramagnetic resonance spin trapping evidence for a radical scavenging mechanism. J Neurochem 2000;75:141-150.
15. Nicolini G, Rigolio R, Scuteri A, Miloso M, Saccomanno D, Cavaletti G, Tredici G: Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 2003;42:419-429.
16. Reagan-Shaw S, Afaq F, Aziz MH, Ahmad N: Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 2004;23:5151-5160.
17. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, Ruparelia KC, Lamb JH, Farmer PB, Stanley LA, Burke MD: The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 2002;86:774-778.
18. Gupta YK, Chaudhary G, Srivastava AK: Protective effect of resveratrol against pentylene-tetrazole-induced seizures and its modulation by an adenosinergic system. Pharmacology 2002;65:170-174.
19. 3-induced model of posttraumatic seizures in rats. Methods Find Exp Clin Pharmacol 2001;23:241-244.
20. Gentilli M, Mazoit JX, Bouaziz H, Fletcher D, Casper RF, Benhamou D, Savouret JF: Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Sci 2001;68:1317-1321.
21. Sharma M, Gupta YK: Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 2002;71:2489-2498.
22. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA: Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003;425:191-196.
23. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D: Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004;430:686-689.
24. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.
25. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu Dos Santos AC, Wood EG, Carrier MJ: Endothelin-1 synthesis reduced by red wine. Nature 2001;414:863-864.
26. Ribeiro de Lima MT, Waffo-Teguo P, Teissedre PL, Pujolas A, Vercauteren J, Cabanis JC, Merillon JM: Determination of stilbenes (trans-astringin, cis- and trans-piceid, and cis-and trans-resveratrol) in Portuguese wines. J Agric Food Chem 1999;47:2666-2670.
27. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Forstermann U: Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002;106:1652-1658.
28. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ: Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998;273:21875-21882.
29. Cheung CY, Chen J, Chang TK: Evaluation of a real-time polymerase chain reaction method for the quantification of CYP1B1 gene expression in MCF-7 human breast carcinoma cells. J Pharmacol Toxicol Methods 2004;49:97-104.
30. Imamura G, Bertelli AA, Bertelli A, Otani H, Maulik N, Das DK: Pharmacological preconditioning with resveratrol: An insight with iNOS knockout mice. Am J Physiol Heart Circ Physiol 2002;282:H1996-H2003.
31. Liu JC, Chen JJ, Chan P, Cheng CF, Cheng TH: Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol. Hypertension 2003;42:1198-1205.
32. Shi T, Liou LS, Sadhukhan P, Duan ZH, Novick AC, Hissong JG, Almasan A, DiDonato JA: Effects of resveratrol on gene expression in renal cell carcinoma. Cancer Biol Ther 2004;3:1538-4047.
33. Ewing JF, Maines MD: Histochemical localization of heme oxygenase-2 protein and mRNA expression in rat brain. Brain Res Brain Res Protoc 1997;1:165-174.
34. Shibahara S, Muller R, Taguchi H, Yoshida T: Cloning and expression of cDNA for rat heme oxygenase. Proc Natl Acad Sci USA 1985;82:7865-7869.
35. Maines MD: The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997;37:517-554.
36. Zhuang H, Pin S, Li X, Doré S: Regulation of heme oxygenase expression by cyclopentenone prostaglandins. Exp Biol Med 2003;228:499-505.
37. Ewing JF, Maines MD: Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: Heme oxygenase 2 is not a heat shock protein. Proc Natl Acad Sci USA 1991;88:5364-5368.
38. Ewing JF, Haber SN, Maines MD: Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: Hyperthermia causes rapid induction of mRNA and protein. J Neurochem 1992;58:1140-1149.
39. Schipper HM, Cisse S, Stopa EG: Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 1995;37:758-768.
40. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen RB, Perry G: Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 1994;145:42-47.
41. Takeda A, Kimpara T, Onodera H, Itoyama Y, Shibahara S, Kogure K: Regional difference in induction of heme oxygenase-1 protein following rat transient forebrain ischemia. Neurosci Lett 1996;205:169-172.
42. Kuroki M, Kanamaru K, Suzuki H, Waga S, Semba R: Effect of vasospasm on heme oxygenases in a rat model of subarachnoid hemorrhage. Stroke 1998;29:683-688; discussion 688-689.
43. Doré S, Sampei K, Goto S, Alkayed NJ, Guastella D, Blackshaw S, Gallagher M, Traystman RJ, Hurn PD, Koehler RC, Snyder SH: Heme oxygenase-2 is neuroprotective in cerebral ischemia. Mol Med 1999;5:656-663.
44. Koistinaho J, Miettinen S, Keinanen R, Vartiainen N, Roivainen R, Laitinen JT: Long-term induction of haem oxygenase-1 (HSP-32) in astrocytes and microglia following transient focal brain ischaemia in the rat. Eur J Neurosci 1996;8:2265-2272.
45. Nimura T, Weinstein PR, Massa SM, Panter S, Sharp FR: Heme oxygenase-1 (HO-1) protein induction in rat brain following focal ischemia. Brain Res Mol Brain Res 1996;37:201-208.
46. Matz P, Weinstein P, States B, Honkaniemi J, Sharp FR: Subarachnoid injections of lysed blood induce the hsp70 stress gene and produce DNA fragmentation in focal areas of the rat brain. Stroke 1996;27:504-512; discussion 513.
47. Yoo MS, Chun HS, Son JJ, DeGiorgio LA, Kim DJ, Peng C, Son JH: Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease. Brain Res Mol Brain Res 2003;110:76-84.
48. Takizawa S, Hirabayashi H, Matsushima K, Tokuoka K, Shinohara Y: Induction of heme oxygenase protein protects neurons in cortex and striatum, but not in hippocampus, against transient forebrain ischemia. J Cereb Blood Flow Metab 1998;18:559-569.
49. Doré S, Law A, Blackshaw S, Gauthier S, Quirion R: Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats. Neuroscience 2000;100:769-775.
50. Panahian N, Yoshiura M, Maines MD: Over-expression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 1999;72:1187-1203.
51. Zhuang H, Kim YS, Greenberg DL, Doré S: Potential mechanism of stilbene neuroprotection. Soc Neurose Abstr 2004;216:12.
52. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Doré S, Poss KD, Snyder SH: Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1999;1:152-157.
53. Poss KD, Tonegawa S: Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997;94:10919-10924.
54. Quinlan GJ, Chen Y, Evans TW, Gutteridge JM: Iron signalling regulated directly and through oxygen: Implications for sepsis and the acute respiratory distress syndrome. Clin Sci (Lond) 2001;100:169-182.
55. Crapper McLachlan DR, Dalton AJ, Kruck TP, Bell MY, Smith WL, Kalow W, Andrews DF: Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 1991;337:1304-1308.
56. Vreman HJ, Wong RJ, Sanesi CA, Dennery PA, Stevenson DK: Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system. Can J Physiol Pharmacol 1998;76:1057-1065.
57. Yoshida T, Noguchi M, Kikuchi G: The step of carbon monoxide liberation in the sequence of heme degradation catalyzed by the reconstituted microsomal heme oxygenase system. J Biol Chem 1982;257:9345-9348.
58. Alkadhi KA, Al-Hijailan RS, Malik K, Hogan YH: Retrograde carbon monoxide is required for induction of long-term potentiation in rat superior cervical ganglion. J Neurosci 2001;21:3515-3520.
59. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH: Carbon monoxide: A putative neural messenger. Science 1993;259:381-384.
60. Maines M: Carbon monoxide and nitric oxide homology: Differential modulation of heme oxygenases in brain and detection of protein and activity. Methods Enzymol 1996;268:473-488.
61. Meffert MK, Haley JE, Schuman EM, Schulman H, Madison DV: Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 1994;13:1225-1233.
62. Poss KD, Thomas MJ, Ebralidze AK, O'Dell TJ, Tonegawa S: Hippocampal long-term potentiation is normal in heme oxygenase-2 mutant mice. Neuron 1995;15:867-873.
63. Linden DJ, Narasimhan K, Gurfel D: Protoporphyrins modulate voltage-gated Ca current in AtT-20 pituitary cells. J Neurophysiol 1993;70:2673-2677.
64. Cowan RL, Doré S: Toxicity and neuroprotective effects of carbon monoxide: Consequences to suicide and survival. Encycl Psychol Behav Sci 2004;3:994-997.
65. Hartsfield CL: Cross talk between carbon monoxide and nitric oxide. Antioxid Redox Signal 2002;4:301-307.
66. Wang R, Wu L: The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 1997;272:8222-8226.
67. Wu L, Cao K, Lu Y, Wang R: Different mechanisms underlying the stimulation of K(Ca) channels by nitric oxide and carbon monoxide. J Clin Invest 2002;110:691-700.
68. Otterbein LE: Carbon monoxide: Innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal 2002;4:309-319.
69. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP: Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. J Biol Chem 2002;277:17950-17961.
70. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA: Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett 1994;349:197-200.
71. Stocker R, Glazer AN, Ames BN: Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 1987;84:5918-5922.
72. Farrera JA, Jauma A, Ribo JM, Peire MA, Parellada PP, Roques-Choua S, Bienvenue E, Seta P: The antioxidant role of bile pigments evaluated by chemical tests. Bioorg Med Chem 1994;2:181-185.
73. Doré S, Takahashi M, Ferris CD, Zakhary R, Hester LD, Guastella D, Snyder SH: Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA 1999;96:2445-2450.
74. Doré S, Snyder SH: Neuroprotective action of bilirubin against oxidative stress in primary hippocampal cultures. Ann NY Acad Sci 1999;890:167-172.
75. Takahashi M, Doré S, Ferris CD, Tomita T, Sawa A, Wolosker H, Borchelt DR, Iwatsubo T, Kim SH, Thinakaran G, Sisodia SS, Snyder SH: Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 2000;28:461-473.
76. Kimpara T, Takeda A, Yamaguchi T, Arai H, Okita N, Takase S, Sasaki H, Itoyama Y: Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. Neurobiol Aging 2000;21:551-554.
77. Zhuang H, Kim YS, Namiranian K, Doré S: Prostaglandins of J series control heme oxygenase expression: Potential significance in modulating neuroinflammation. Ann N Y Acad Sci 2003;993:208-216.
78. Bishop A, Cashman NR: Induced adaptive resistance to oxidative stress in the CNS: A discussion on possible mechanisms and their therapeutic potential. Curr Drug Metab 2003;4:171-184.
79. Goto S, Sampei K, Alkayed NJ, Doré S, Koehler RC: Characterization of a new double-filament model of focal cerebral ischemia in heme oxygenase-2-deficient mice. Am J Physiol Regul Integr Comp Physiol 2003;285:R222-R230.
80. Doré S, Goto S, Sampei K, Blackshaw S, Hester LD, Ingi T, Sawa A, Traystman RJ, Koehler RC, Snyder SH: Heme oxygenase-2 acts to prevent neuronal cell death in brain cultures and following transient cerebral ischemia. Neuroscience 2000;99:587-592.
81. Calabrese V, Butterfield DA, Stella AM: Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: Novel targets for neuroprotection in Alzheimer's disease. Ital J Biochem 2003;52:177-181.
82. Schipper HM, Cisse S, Stopa EG: Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann Neurol 1995;37:758-768.
83. Wagner KR, Sharp FR, Ardizzone TD, Lu A, Clark JF: Heme and iron metabolism: Role in cerebral hemorrhage. J Cereb Blood Flow Metab 2003;23:629-652.
84. Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J, Connor J: Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res 2003;71:46-63.
85. Krieger J, Schroeder C: Iron, brain and restless legs syndrome. Sleep Med Rev 2001;5:277-286.
86. Ponka P: Hereditary causes of disturbed iron homeostasis in the central nervous system. Ann NY Acad Sci 2004;1012:267-281.
87. Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL: Aceruloplasminemia: An inherited neurodegenerative disease with impairment of iron homeostasis. Ann NY Acad Sci 2004;1012:299-305.
88. Crompton DE, Chinnery PF, Fey C, Curtis AR, Morris CM, Kierstan J, Burt A, Young F, Coulthard A, Curtis A, Ince PG, Bates D, Jackson MJ, Burn J: Neuroferritinopathy: A window on the role of iron in neurodegeneration. Blood Cells Mol Dis 2002;29:522-531.
89. Reid G: Association of sudden infant death syndrome with grossly deranged iron metabolism and nitric oxide overload. Med Hypotheses 2000;54:137-139.
90. Artinian LR, Ding JM, Gillette MU: Carbon monoxide and nitric oxide: Interacting messengers in muscarinic signaling to the brain's circadian clock. Exp Neurol 2001;171:293-300.
91. Dioum EM, Rutter J, Tuckerman JR, Gonzalez G, Gilles-Gonzalez MA, McKnight SL: NPAS2: a gas-responsive transcription factor. Science 2002;298:2385-2387.
92. Ilzecka J, Stelmasiak Z: Serum bilirubin concentration in patients with amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2003;105:237-240.
93. Gordh T, Sharma HS, Azizi M, Aim P, Westman J: Spinal nerve lesion induces upregulation of constitutive isoform of heme oxygenase in the spinal cord. An immunohistochemical investigation in the rat. Amino Acids 2000;19:373-381.
94. Beschorner R, Adjodah D, Schwab JM, Mittelbronn M, Pedal I, Mattern R, Schluesener HJ, Meyermann R: Long-term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol (Berl) 2000;100:377-384.
95. Browne SE, Ferrante RJ, Beal MF: Oxidative stress in Huntington's disease. Brain Pathol 1999;9:147-163.
96. Cooke RW: New approach to prevention of kernicterus. Lancet 1999;353:1814-1815.
97. Hara E, Takahashi K, Tominaga T, Kumabe T, Kayama T, Suzuki H, Fujita H, Yoshimoto T, Shirato K, Shibahara S: Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochem Biophys Res Commun 1996;224:153-158.
98. Solowiej E, Kasprzycka-Guttman T, Fiedor P, Rowinski W: Chemoprevention of cancerogenesis - the role of sulforaphane. Acta Pol Pharm 2003;60:97-100.
99. Liang DY, Li X, Clark JD: Formalin-induced spinal cord calcium/calmodulin-dependent protein kinase II alpha expression is modulated by heme oxygenase in mice. Neurosci Lett 2004;360:61-64.
100. Carratu P, Pourcyrous M, Fedinec A, Leffler CW, Parfenova H: Endogenous heme oxygenase prevents impairment of cerebral vascular functions caused by seizures. Am J Physiol 2003;285:H1148-H1157.
101. Zhuang H, Littleton-Kearney MT, Doré S: Characterization of heme oxygenase in adult rodent platelets. Curr Neurovasc Res 2004; in press.
102. Law A, Doré S, Blackshaw S, Gauthier S, Quirion R: Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats. Neuroscience 2000;100:769-775.